Molina Healthcare, Inc. Stock News

Molina Healthcare, Inc. (NYSE:MOH ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President and CEO Mark Keim - CFO Conference Call Participants Stephen Baxter - Wells Fargo Andrew Mok - Barclays Josh Raskin - Nephron Research A.J. Rice - UBS Justin Lake - Wolfe Research John Stansel - JP Morgan Sarah J...

Molina Healthcare beat Wall Street estimates for first-quarter earnings on Wednesday, driven by an increase in premiums from its government-backed Medicaid insurance plans for people with low income.

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:   Three months ended   March 31,   2025   2024         (In millions, except per-share results) Premium Revenue $10,628   $9,504 Total Revenue $...

SACRAMENTO, Calif.--(BUSINESS WIRE)--Molina Healthcare of California opens its first northern California One Stop Help Center.

Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.

Molina Healthcare, Inc.'s stock has shown resilience, with an over 15% YTD gain, despite broader market challenges, reflecting steady growth and strong operational performance. The company has achieved significant revenue and earnings growth, with a clear strategy targeting $52-$55 billion in premium revenue by 2027. Molina's diversified business across Medicaid, Medicare, and marketplace segme...

During the recent market turmoil, three healthcare stocks have performed very well. Those stocks are deeply involved in the health insurance industry.

Potato maker Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc., drug maker AbbVie Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to stocks offering exposure to tariff-resistant businesses such as food, prescription drugs and subscription revenue.